The KEGG pathway analysis showed that triptolide regulated the activation of pancreatic cancer, rheumatoid arthritis, and AGE-RAGE signaling pathway in diabetic complications in the treatment of DCM. This evidence concerns the gene RENBP and pancreatic neoplasm.